Literature DB >> 21562448

Evolving strategies in the management of submacular hemorrhage associated with choroidal neovascularization in the anti-vascular endothelial growth factor era.

Bozho Todorich, Ingrid U Scott, Harry W Flynn, Mark W Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21562448     DOI： 10.1097/IAE.0b013e31821504df

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy.

Authors:  Chui Ming Gemmy Cheung; Mayuri Bhargava; Li Xiang; Ranjana Mathur; Chan Choi Mun; Doric Wong; Tien Yin Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-26       Impact factor: 3.117

2.  Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Authors:  Michael M Altaweel; Ebenezer Daniel; Daniel F Martin; Robert A Mittra; Juan E Grunwald; Michael M Lai; Alexander Melamud; Lawrence S Morse; Jiayan Huang; Frederick L Ferris; Stuart L Fine; Maureen G Maguire
Journal:  Ophthalmology       Date:  2014-10-11       Impact factor: 12.079

3.  Submacular hemorrhage secondary to age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, hemorrhage displacement with liquid perfluorocarbon, gas tamponade, and face-down positioning.

Authors:  Abdullah Ozkaya; Gurkan Erdogan; Hatice Nur Tarakcioglu
Journal:  Saudi J Ophthalmol       Date:  2018-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.